Anavex Life Sciences
AVXL
#7563
Rank
NZ$0.68 B
Marketcap
NZ$7.62
Share price
-1.12%
Change (1 day)
-44.96%
Change (1 year)

EPS for Anavex Life Sciences (AVXL)

EPS in 2025 (TTM): NZ-$0.97

According to Anavex Life Sciences 's latest financial reports the company's current EPS (TTM) is NZ-$0.99. In 2024 the company made an earnings per share (EPS) of NZ-$0.90 an increase over its 2023 EPS that were of NZ-$1.04.

EPS history for Anavex Life Sciences from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$0.977.73%
2024NZ-$0.90-13.33%
2023NZ-$1.04-3.23%
2022NZ-$1.0714.81%
2021NZ-$0.9320%
2020NZ-$0.78-16.67%
2019NZ-$0.9338.46%
2018NZ-$0.6818.18%
2017NZ-$0.57-21.43%
2016NZ-$0.73-35.38%
2015NZ-$1.13-36.27%
2014NZ-$1.77112.5%
2013NZ-$0.83-58.62%
2012NZ-$2.01-0%
2011NZ-$2.01-29.27%
2010NZ-$2.8451.85%
2009NZ-$1.87-0%
2008NZ-$1.87237.5%
2007NZ-$0.55
2006N/A-100%
2005NZ-$0.06924499.97%
2004NZ-$0.01154

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ligand Pharmaceuticals
LGND
NZ$4.14-519.30%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
NZ-$0.08655-91.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
NZ$1.73-275.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
NZ-$105.59 10,601.75%๐Ÿ‡บ๐Ÿ‡ธ USA